MedTrace Logo

Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study

NCT03846947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-05-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate potential clinical efficacy of a novel magnetic resonance imaging (MRI) approach, MR fingerprinting, capable of providing quantitative measures of important tissue properties, which could provide important insights into normal breast tissue. This new MRI sequence will be added to the screening breast Dynamic Contrast Enhanced (DCE) MRI for high risk normal patients.

Conditions

  • Breast Screening

Interventions

DEVICE

MR Fingerprinting

The MR fingerprinting technique requires less than 15 minutes total and will be added before and after the standard MRI sequence.

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Cherie Kuzmiak, DO,FACR,FSBI · UNC Chapel Hill

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2022-06-21
Completion
2022-06-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03846947 on ClinicalTrials.gov